 Abigail Lara
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arginine | 3 | 2017 | 259 | 0.610 |
Why?
| | Nitric Oxide | 4 | 2017 | 881 | 0.480 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 60 | 0.390 |
Why?
| | Collagen | 2 | 2012 | 429 | 0.360 |
Why?
| | Arginase | 1 | 2008 | 32 | 0.300 |
Why?
| | Fibroblasts | 1 | 2012 | 934 | 0.280 |
Why?
| | Lung Diseases, Interstitial | 2 | 2012 | 592 | 0.270 |
Why?
| | Hemorrhage | 1 | 2010 | 643 | 0.250 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2703 | 0.230 |
Why?
| | Lung Diseases | 1 | 2010 | 713 | 0.210 |
Why?
| | Pulmonary Artery | 2 | 2007 | 1030 | 0.200 |
Why?
| | Pulmonary Fibrosis | 3 | 2011 | 377 | 0.200 |
Why?
| | Asthma | 3 | 2017 | 2212 | 0.200 |
Why?
| | Bronchoalveolar Lavage | 2 | 2013 | 89 | 0.190 |
Why?
| | Bleomycin | 2 | 2011 | 240 | 0.160 |
Why?
| | Biopsy | 3 | 2013 | 1077 | 0.160 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2016 | 623 | 0.140 |
Why?
| | Hypertension, Pulmonary | 3 | 2011 | 1747 | 0.130 |
Why?
| | Cholestyramine Resin | 1 | 2015 | 7 | 0.130 |
Why?
| | Bronchi | 1 | 2017 | 241 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2012 | 3324 | 0.120 |
Why?
| | Isoxazoles | 1 | 2015 | 54 | 0.120 |
Why?
| | Prosthesis-Related Infections | 1 | 2015 | 73 | 0.120 |
Why?
| | Breath Tests | 2 | 2017 | 89 | 0.110 |
Why?
| | Mucin-5B | 1 | 2016 | 217 | 0.110 |
Why?
| | Shock, Septic | 1 | 2015 | 207 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 12 | 0.100 |
Why?
| | Anesthesia, General | 1 | 2013 | 49 | 0.100 |
Why?
| | Transforming Growth Factor beta | 2 | 2012 | 443 | 0.100 |
Why?
| | Antirheumatic Agents | 1 | 2015 | 278 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 15 | 0.100 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 25 | 0.100 |
Why?
| | Silicosis | 1 | 2013 | 27 | 0.100 |
Why?
| | Lung Injury | 2 | 2011 | 199 | 0.090 |
Why?
| | Myofibroblasts | 1 | 2012 | 119 | 0.090 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1198 | 0.090 |
Why?
| | Lung | 3 | 2013 | 3745 | 0.090 |
Why?
| | Lactic Acid | 1 | 2012 | 294 | 0.090 |
Why?
| | Gene Expression | 1 | 2016 | 1454 | 0.090 |
Why?
| | Plasmapheresis | 1 | 2010 | 22 | 0.090 |
Why?
| | Spirometry | 2 | 2008 | 252 | 0.090 |
Why?
| | Radiography | 1 | 2012 | 794 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 499 | 0.080 |
Why?
| | Biological Availability | 1 | 2008 | 130 | 0.070 |
Why?
| | Respiration, Artificial | 2 | 2013 | 600 | 0.070 |
Why?
| | Pulmonary Alveoli | 1 | 2010 | 365 | 0.070 |
Why?
| | Adrenal Cortex Hormones | 1 | 2010 | 518 | 0.070 |
Why?
| | Receptors, Immunologic | 1 | 2007 | 215 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 682 | 0.060 |
Why?
| | Humans | 15 | 2017 | 128019 | 0.060 |
Why?
| | Mitral Valve Insufficiency | 1 | 2005 | 67 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2012 | 1896 | 0.060 |
Why?
| | Lung Transplantation | 1 | 2007 | 278 | 0.060 |
Why?
| | Male | 10 | 2017 | 62757 | 0.060 |
Why?
| | Female | 11 | 2017 | 68016 | 0.060 |
Why?
| | Myocardial Ischemia | 1 | 2005 | 247 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2337 | 0.050 |
Why?
| | Kidney Calculi | 1 | 2003 | 35 | 0.050 |
Why?
| | Superoxide Dismutase | 1 | 2005 | 333 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1921 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2005 | 383 | 0.050 |
Why?
| | Sulfonamides | 1 | 2005 | 494 | 0.050 |
Why?
| | Antihypertensive Agents | 1 | 2005 | 481 | 0.050 |
Why?
| | Glycolysis | 2 | 2017 | 293 | 0.050 |
Why?
| | Aged | 4 | 2015 | 21892 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2016 | 1020 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2007 | 844 | 0.040 |
Why?
| | Middle Aged | 5 | 2012 | 30812 | 0.040 |
Why?
| | Respiratory Insufficiency | 2 | 2013 | 311 | 0.040 |
Why?
| | Kidney Failure, Chronic | 1 | 2003 | 540 | 0.040 |
Why?
| | Adult | 5 | 2017 | 35176 | 0.040 |
Why?
| | Exhalation | 1 | 2017 | 38 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 603 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2017 | 168 | 0.030 |
Why?
| | Acute Kidney Injury | 1 | 2003 | 777 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2015 | 87 | 0.030 |
Why?
| | Respiratory Mucosa | 1 | 2017 | 304 | 0.030 |
Why?
| | One-Lung Ventilation | 1 | 2013 | 2 | 0.030 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2013 | 17 | 0.030 |
Why?
| | Lung Compliance | 1 | 2011 | 45 | 0.020 |
Why?
| | Chemokine CXCL1 | 1 | 2011 | 73 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 104 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 2013 | 238 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2011 | 5268 | 0.020 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2011 | 183 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 961 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 815 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2011 | 624 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2015 | 10110 | 0.020 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2007 | 30 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1262 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1870 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2011 | 719 | 0.020 |
Why?
| | Hypoxia | 1 | 2013 | 1034 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 509 | 0.020 |
Why?
| | Sex Factors | 1 | 2011 | 1942 | 0.020 |
Why?
| | Glutathione Peroxidase | 1 | 2005 | 43 | 0.020 |
Why?
| | Cicatrix | 1 | 2005 | 59 | 0.010 |
Why?
| | Mitral Valve | 1 | 2005 | 85 | 0.010 |
Why?
| | Linear Models | 1 | 2007 | 816 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 2007 | 469 | 0.010 |
Why?
| | Mice | 2 | 2011 | 16574 | 0.010 |
Why?
| | Anuria | 1 | 2003 | 4 | 0.010 |
Why?
| | Proteus mirabilis | 1 | 2003 | 3 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3100 | 0.010 |
Why?
| | Proteus Infections | 1 | 2003 | 5 | 0.010 |
Why?
| | Forced Expiratory Volume | 1 | 2005 | 509 | 0.010 |
Why?
| | Airway Obstruction | 1 | 2005 | 149 | 0.010 |
Why?
| | Glutathione | 1 | 2005 | 340 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 2005 | 580 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2134 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2003 | 389 | 0.010 |
Why?
| | Echocardiography | 1 | 2005 | 623 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2007 | 734 | 0.010 |
Why?
| | Oxygen | 1 | 2007 | 899 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 1934 | 0.010 |
Why?
| | Length of Stay | 1 | 2007 | 1114 | 0.010 |
Why?
| | Pneumonia | 1 | 2007 | 600 | 0.010 |
Why?
| | Amino Acids | 1 | 2005 | 476 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2007 | 831 | 0.010 |
Why?
| | Mitochondria | 1 | 2007 | 847 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2010 | 14404 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2005 | 765 | 0.010 |
Why?
| | Animals | 2 | 2011 | 34487 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2007 | 4006 | 0.010 |
Why?
| | Prognosis | 1 | 2007 | 3766 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2005 | 675 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2005 | 1181 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7029 | 0.010 |
Why?
| | Cohort Studies | 1 | 2007 | 5378 | 0.010 |
Why?
| | Biomarkers | 1 | 2007 | 3874 | 0.010 |
Why?
| | Prospective Studies | 1 | 2007 | 7035 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3371 | 0.010 |
Why?
|
|
Lara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|